Filing Details
- Accession Number:
- 0001357211-12-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-06 21:36:31
- Reporting Period:
- 2012-09-04
- Filing Date:
- 2012-09-06
- Accepted Time:
- 2012-09-06 21:36:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1159019 | Stellar Pharmaceuticals Inc | SLXCF | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1489399 | Harold Steven Goldman | 22 Vesta Drive Toronto A6 M5P 2Z5 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Share | Acquisiton | 2012-09-04 | 20,500 | $0.50 | 1,020,646 | No | 4 | P | Indirect | Lambent Consulting Corp |
Common Shares | Acquisiton | 2012-09-05 | 44,500 | $0.50 | 1,065,146 | No | 4 | P | Indirect | Lambent Consulting Corp |
Common Shares | Acquisiton | 2012-09-05 | 30,000 | $0.49 | 1,095,146 | No | 4 | P | Indirect | Lambent Consulting Corp |
Common Shares | Acquisiton | 2012-09-05 | 10,000 | $0.51 | 1,105,146 | No | 4 | P | Indirect | Lambent Consulting Corp |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Lambent Consulting Corp |
No | 4 | P | Indirect | Lambent Consulting Corp |
No | 4 | P | Indirect | Lambent Consulting Corp |
No | 4 | P | Indirect | Lambent Consulting Corp |